BRIEF published on 02/12/2026 at 21:15, 4 months 17 days ago Le groupe Vanguard dévoile sa position dans le secteur de la finance personnelle internationale Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Information Sur Les Valeurs Mobilières Finances Personnelles Internationales
PRESS RELEASE published on 02/12/2026 at 21:15, 4 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited The Vanguard Group, Inc. discloses a 1.25% stake in Bluefield Solar Income Fund Limited as of 11 Feb 2026, with 30,476 shares purchased at 0.76 GBP per share The Vanguard Group Financial Disclosure Share Purchase Stake Disclosure Bluefield Solar Income Fund Limited
BRIEF published on 02/12/2026 at 21:15, 4 months 17 days ago The Vanguard Group Discloses Position in Picton Property Income Limited Securities Disclosure Takeover Code Vanguard Picton Property
BRIEF published on 02/12/2026 at 21:15, 4 months 17 days ago Le groupe Vanguard révèle sa participation dans Picton Property Income Limited Titres Code De Prise De Contrôle Divulgation Avant-garde Propriété Picton
PRESS RELEASE published on 02/12/2026 at 21:14, 4 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.03% interest in Beazley plc through Form 8.3. Transactions include purchases and sales of 5p ordinary shares Transactions The Vanguard Group, Inc. Form 8.3 Disclosure Beazley Plc
BRIEF published on 02/12/2026 at 21:14, 4 months 17 days ago The Vanguard Group Discloses Position in NCC Group plc Disclosure Takeover Code Vanguard Group Shareholding NCC Group
BRIEF published on 02/12/2026 at 21:14, 4 months 17 days ago Le groupe Vanguard révèle sa participation dans NCC Group plc Actionnariat Groupe Vanguard Code De Prise De Contrôle Divulgation Groupe NCC
PRESS RELEASE published on 02/12/2026 at 21:13, 4 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.61% interest in Spire Healthcare Group plc as per Form 8.3 submitted under Rule 8.3 of the Takeover Code Form 8.3 The Vanguard Group Takeover Code Interest Disclosure Spire Healthcare Group Plc
PRESS RELEASE published on 02/12/2026 at 21:13, 4 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Oxford Biomedica plc The Vanguard Group, Inc. discloses a 1.01% interest in Oxford Biomedica plc. Purchase of 3,890 securities at 8.16 GBP per unit on 11 Feb 2026 Securities Disclosure Vanguard Group Purchase Oxford Biomedica Plc
PRESS RELEASE published on 02/12/2026 at 21:11, 4 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses a 4.92% stake in Just Group plc as of 11th Feb 2026. Details of securities interests and transactions provided in Form 8.3 Securities Form 8.3 Disclosure The Vanguard Group Just Group Plc
Published on 06/29/2026 at 22:01, 1 hour 48 minutes ago AIP Realty Trust Announces Voting Results of Annual General and Special Meeting of Unitholders
Published on 06/29/2026 at 15:00, 8 hours 49 minutes ago Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah
Published on 06/29/2026 at 15:00, 8 hours 49 minutes ago Vox Royalty Highlights Significant Gold Offtake-Stream Exposure to Los Filos Following Key Milestone Announcement
Published on 06/29/2026 at 14:30, 9 hours 19 minutes ago Unusual Machines Added to Russell 2000(R) Index
Published on 06/29/2026 at 14:30, 9 hours 19 minutes ago Sekur Private Data Makes First Intl. Call on SekurOne - Launches SekurOne for Android and Web
Published on 06/29/2026 at 22:47, 1 hour 2 minutes ago Correction d’un communiqué du 29.06.2026 22:05 CET/CEST - ABIVAX: Résultats positifs de la partie 2 de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les ...
Published on 06/29/2026 at 22:05, 1 hour 44 minutes ago ABIVAX: Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité
Published on 06/29/2026 at 22:05, 1 hour 44 minutes ago Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory UC Patients and Strengthening the Phase 3 Maintenance Safety Database
Published on 06/29/2026 at 20:30, 3 hours 19 minutes ago Shelly Group SE: Annual General Meeting approves dividend of EUR 0.13 per share – shareholders approve all agenda items
Published on 06/29/2026 at 20:00, 3 hours 49 minutes ago IGEL Appoints James Millington as Field CTO for Healthcare in EMEA
Published on 06/29/2026 at 18:30, 5 hours 19 minutes ago Accor and H World Group expand long-term partnership across direct booking and loyalty platforms
Published on 06/29/2026 at 18:30, 5 hours 19 minutes ago Accor et H World Group : extension du partenariat de long terme aux plateformes de réservation directe et de fidélité
Published on 06/29/2026 at 17:45, 6 hours 4 minutes ago Succès de l’émission obligataire de 1,5 milliard d’euros
